Azioni Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Azioni
TEVA
IL0006290147
Prodotti farmaceutici
Fatturato 2024 * | 15,86 Mrd 60,29 Mrd 14,91 Mrd | Fatturato 2025 * | 16,35 Mrd 62,12 Mrd 15,36 Mrd | Capitalizzazione | 14,48 Mrd 55,01 Mrd 13,61 Mrd |
---|---|---|---|---|---|
Risultato netto 2024 * | 1,54 Mrd 5,85 Mrd 1,45 Mrd | Risultato netto 2025 * | 1,44 Mrd 5,48 Mrd 1,36 Mrd | EV/Fatturato 2024 * | 1,83 x |
Indebitamento netto 2024 * | 14,62 Mrd 55,57 Mrd 13,74 Mrd | Indebitamento netto 2025 * | 12,12 Mrd 46,06 Mrd 11,39 Mrd | EV/Fatturato 2025 * | 1,63 x |
P/E ratio 2024 * |
10,2
x | P/E ratio 2025 * |
9,55
x | Dipendenti | - |
Rendimento 2024 * |
-
| Rendimento 2025 * |
-
| Flottante | 89,71% |
Ultimo resoconto su Teva Pharmaceutical Industries Limited
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/09/15 |
Janet Vergis
BRD | Director/Board Member | 60 | 09/06/20 |
Sol Barer
CHM | Chairman | 76 | 01/01/15 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+27,97% | 676 Mrd | |
+23,58% | 554 Mrd | |
-7,02% | 349 Mrd | |
+14,85% | 318 Mrd | |
+6,25% | 291 Mrd | |
+2,96% | 210 Mrd | |
-0,41% | 204 Mrd | |
-10,02% | 194 Mrd | |
-11,81% | 144 Mrd |